默沙东在ACC.26大会展示心肺部研发管线新数据,彰显推进创新研究承诺

美股速递
Mar 16

在近期举行的美国心脏病学会年度科学会议(ACC.26)上,默沙东(Merck)重点公布了其心肺部疾病研发管线中的多项新数据。此次发布突显了公司致力于推动创新疗法研究的坚定承诺,为相关领域的前沿探索提供了重要科学依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10